Published in Drug Week, September 26th, 2003
Following its approval for Medicaid reimbursement, Resurgex, according to the company, is becoming an important adjunct therapy for immune-compromised individuals.
Millennium Biotechnologies is focused on nutritional science.
This article was prepared by Drug Week...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.